PHMR

Pfizer CEO rules out generic COVID drug Paxlovid for China

by

Jan. 9 (Reuters) – Pfizer Inc (PFE.N) It’s not in talks with Chinese authorities to license a generic version of its COVID-19 treatment Paxlovid for use there, CEO Albert Bourla said Monday, but it is in discussions about the price of the branded product. Reuters reported on Friday that China is in talks with Pfizer … Read more

Chinese media downplays the severity of COVID as the World Health Organization seeks details about the variants

by

State media says severe illness from the coronavirus is rare Chinese scientists brief the World Health Organization Chinese factory activity contracted in December BEIJING/HONG KONG/GENEVA, Jan. 3 (Reuters) – China’s state media downplayed the severity of a surge in COVID-19 infections on Tuesday, while its scientists briefed the World Health Organization, which is seeking detailed … Read more